| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 14.46% | Goldman Sachs | $20.5 → $19 | Maintains | Neutral |
| 10/20/2023 | 29.52% | HSBC | → $21.5 | Upgrades | Hold → Buy |
| 10/05/2023 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 10/04/2023 | 32.53% | UBS | $25 → $22 | Upgrades | Neutral → Buy |
| 09/19/2023 | 32.53% | Goldman Sachs | $25 → $22 | Maintains | Neutral |
| 08/29/2023 | 5.42% | JP Morgan | $19 → $17.5 | Maintains | Underweight |
| 08/17/2023 | 41.57% | Citigroup | → $23.5 | Upgrades | Neutral → Buy |
| 07/20/2023 | 50.6% | Goldman Sachs | $24 → $25 | Maintains | Neutral |
| 05/31/2023 | 44.58% | Goldman Sachs | → $24 | Initiates Coverage On | → Neutral |
| 05/16/2023 | 62.65% | New Street Research | $21 → $27 | Upgrades | Neutral → Buy |
| 03/24/2023 | — | LightShed Partners | Initiates Coverage On | → Neutral | |
| 11/28/2022 | 35.54% | UBS | $20.4 → $22.5 | Downgrades | Buy → Neutral |
| 10/26/2022 | 44.58% | Goldman Sachs | $28 → $24 | Maintains | Buy |
| 10/17/2022 | 20.48% | Barclays | $22 → $20 | Maintains | Overweight |
| 09/20/2022 | 22.89% | UBS | $20.5 → $20.4 | Upgrades | Neutral → Buy |
| 09/20/2022 | — | Piper Sandler | Upgrades | Neutral → Buy | |
| 08/04/2022 | 38.55% | Citigroup | → $23 | Upgrades | Neutral → Buy |
| 07/14/2022 | 32.53% | Barclays | $23 → $22 | Maintains | Overweight |
| 03/18/2022 | 26.51% | JP Morgan | $23 → $21 | Downgrades | Overweight → Neutral |
| 10/14/2021 | 26.51% | Barclays | $19 → $21 | Maintains | Overweight |
| 10/06/2021 | 14.46% | Itau BBA | → $19 | Downgrades | Outperform → Market Perform |
| 08/17/2020 | 2.41% | Barclays | $16 → $17 | Maintains | Overweight |
| 07/16/2020 | 2.41% | Scotiabank | $16 → $17 | Maintains | Sector Outperform |
| 06/04/2020 | -9.64% | Itau BBA | → $15 | Upgrades | Market Perform → Outperform |
| 04/05/2019 | 2.41% | JP Morgan | $16 → $17 | Upgrades | Neutral → Overweight |
| 11/26/2018 | — | Bradesco Corretora | Upgrades | → Neutral |
What is the target price for America Movil (AMX)?
The latest price target for America Movil (NYSE: AMX) was reported by Goldman Sachs on October 25, 2023. The analyst firm set a price target for $19.00 expecting AMX to rise to within 12 months (a possible 14.46% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for America Movil (AMX)?
The latest analyst rating for America Movil (NYSE: AMX) was provided by Goldman Sachs, and America Movil maintained their neutral rating.
When is the next analyst rating going to be posted or updated for America Movil (AMX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of America Movil, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for America Movil was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating America Movil (AMX) correct?
While ratings are subjective and will change, the latest America Movil (AMX) rating was a maintained with a price target of $20.50 to $19.00. The current price America Movil (AMX) is trading at is $16.60, which is out of the analyst's predicted range.